|
|
||||||||
| Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology. |
From the Movement Disorders Program, Department of Neurology, Emory University School of Medicine & Wesley Woods Geriatric Center, Atlanta, GA.
Address correspondence and reprint requests to Dr. Ray L. Watts, Emory University School of Medicine, Department of Neurology, 1639 Pierce Drive, WMRB Suite 6000, Atlanta, GA 30322; e-mail: rwatts2{at}emory.edu
Article abstractDepression associated with Parkinsons disease (PD) is common and affects 25 to 40% of patients. Recognition of the signs and symptoms of depression associated with PD is essential for clinical practitioners. Treatment of depression in this subset of patients can have a direct and dramatic impact on functional disability and quality of life. A review of the literature concerning depression and depression associated with PD was undertaken, with specific attention given to disease mechanisms, clinical presentation, association with thyroid disease, and the principles of management and treatment. Specific signs and symptoms of depression can be easily identified in patients with PD. Practitioners should be aware of these signs and symptoms when diagnosing and treating depression associated with PD. Practitioners should also be aware of the pros and cons of each treatment option and should choose a therapy appropriate for each individual patients needs. It is important to identify the features of depression associated with PD in order to render early diagnosis and institute practical and efficacious therapy.
This article has been cited by other articles:
![]() |
W.M.M. Schupbach, D. Maltete, J. L. Houeto, S. T. du Montcel, L. Mallet, M. L. Welter, M. Gargiulo, C. Behar, A. M. Bonnet, V. Czernecki, et al. Neurosurgery at an earlier stage of Parkinson disease: A randomized, controlled trial Neurology, January 23, 2007; 68(4): 267 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Sienkiewicz-Jarosz, A Scinska, W Kuran, D Ryglewicz, A Rogowski, E Wrobel, A Korkosz, A Kukwa, W Kostowski, and P Bienkowski Taste responses in patients with Parkinson's disease J. Neurol. Neurosurg. Psychiatry, January 1, 2005; 76(1): 40 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.E. Lang, G. Kleiner-Fisman, J.A. Saint-Cyr, J. Miyasaki, A. Lozano, J.L. Houeto, V. Mesnage, M.L. Welter, L. Mallet, Y. Agid, et al. Subthalamic DBS replaces levodopa in Parkinson's disease: Two-year follow-up Neurology, January 14, 2003; 60(1): 154 - 155. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |